NEW YORK (GenomeWeb) – Clinical genomics interpretation software vendor Congenica is pushing deeper into China by adding Digital China Health Technologies as a strategic partner.

Cambridge, England-based Congenica said today that it will work with the Hong Kong-based company, branded as DCHealth, to tailor its its flagship Sapientia genome analysis platform for the Chinese market. DCHealth, which has a strong presence in Chinese hospitals, will lead the marketing of this localized version of Sapienta, the companies said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.